thirty The existing study demonstrates fluorescently-label MUC4 antibody has medical possible to enhance R0 resection of CRC cancer, Particularly CRLM, which would be a very important progress in the sphere of FGS.Individuals which has a history of a latest or remote bariatric surgical procedure are in danger for many different acute care surgical